The global EPA and DHA Market is estimated to be valued at US$ 1,626.10 Mn in 2022 and is expected to exhibit a CAGR of 6.76% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. The market is witnessing significant growth due to the increasing awareness about the health benefits of Omega-3 fatty acids, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). These omega-3 fatty acids are essential for brain development, heart health, and overall well-being. The market is also driven by the rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and obesity, wherein EPA and DHA play a crucial role in prevention and management. However, the high cost associated with production and stringent regulations related to fish oil extraction are major obstacles in the market.
Market Key Trends:
One key trend in the EPA And DHA Market is the increasing demand for vegan and vegetarian sources of Omega-3 fatty acids. As consumers are adopting plant-based diets and looking for alternatives to fish oil, companies are developing innovative products derived from algae and other plant sources that provide EPA and DHA. For example, DSM NV offers a vegetarian source of omega-3 fatty acids derived from algae, which provides a sustainable and cruelty-free option for consumers.
The EPA and DHA market is segmented based on the source type, which includes fish oil, algal oil, and other sources. Among these, algal oil is expected to dominate the market during the forecast period. Algal oil is extracted from microalgae, which are rich in EPA and DHA. It provides a sustainable and renewable source of omega-3 fatty acids without the environmental concerns associated with fish oil extraction. With the increasing demand for vegan and vegetarian products, algal oil has gained significant popularity in the market.
The global EPA And DHA Market is expected to witness high growth, exhibiting a CAGR of 6.76% over the forecast period. The increasing demand for Omega-3 fatty acids, driven by their health benefits, is a major factor contributing to market growth. Omega-3 fatty acids have been proven to reduce the risk of heart disease, improve brain function, support eye health, and have anti-inflammatory properties. Additionally, the rising prevalence of chronic diseases and the incorporation of EPA and DHA in dietary supplements and functional foods are further propelling market growth.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the EPA and DHA market. This is attributed to the high consumer awareness about the health benefits of Omega-3 fatty acids, along with the presence of key market players in the region. The Asia Pacific region is also expected to witness significant growth due to the increasing disposable income, changing dietary patterns, and rising health consciousness among consumers.
Key players operating in the global EPA and DHA market include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris. These companies are focusing on product development, strategic partnerships, and mergers & acquisitions to expand their market presence and cater to the growing demand for EPA and DHA products globally.
Overall, the EPA and DHA market is witnessing significant growth due to the increasing demand for Omega-3 fatty acids and their health benefits. With the advent of plant-based alternatives and sustainable sourcing methods, the market is expected to continue its upward trajectory in the coming years.